D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKS
1601
DELISTED
AK Steel Holding Corp
AKS
| $3.5M | 0.01% |
784,121
-704,963
| -47% | -$3.07M |
|
1602
StoneX
SNEX
$8.85B
| $3.5M | 0.01% |
596,221
+361,868
| +154% | +$1.74M |
|
1603
Fresenius Medical Care
FMS
$13.4B
| $3.5M | 0.01% |
84,331
-61,877
| -42% | -$2.39M |
|
1604
Entravision Communication
EVC
$1.02B
| $3.48M | 0.01% |
550,393
-83,934
| -13% | -$555K |
|
1605
Phibro Animal Health
PAHC
$1.43B
| $3.48M | 0.01% |
98,368
-230,851
| -70% | -$7.43M |
|
1606
PUT
Nabors Industries
NBR
$1.16B
| $3.48M | 0.01% |
5,100
+600
| +13% | +$366K |
|
|
ESRX
1607
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $3.48M | 0.01% |
40,100
| – | – |
|
|
WSTC
1608
DELISTED
West Corporation
WSTC
| $3.48M | 0.01% |
+103,117
| New | +$3.42M |
|
1609
Griffon
GFF
$4.28B
| $3.47M | 0.01% |
199,194
-16,945
| -8% | -$261K |
|
|
ARI
1610
Apollo Commercial Real Estate
ARI
$876M
| $3.47M | 0.01% |
201,932
+35,749
| +22% | +$602K |
|
|
RDC
1611
PUT
DELISTED
Rowan Companies Plc
RDC
| $3.47M | 0.01% |
195,900
+40,000
| +26% | +$853K |
|
1612
Axalta
AXTA
$7.22B
| $3.47M | 0.01% |
+125,489
| New | +$3.38M |
|
|
CBPO
1613
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $3.46M | 0.01% |
36,254
+6,680
| +23% | +$500K |
|
|
MAG
1614
DELISTED
MAG Silver
MAG
| $3.45M | 0.01% |
557,700
+57,700
| +12% | +$419K |
|
1615
CALL
Viatris
VTRS
$20.5B
| $3.45M | 0.01% |
58,100
-31,100
| -35% | -$1.77M |
|
|
IVC
1616
DELISTED
Invacare Corporation
IVC
| $3.45M | 0.01% |
177,651
+82,157
| +86% | +$1.42M |
|
1617
Unilever
UL
$132B
| $3.44M | 0.01% |
+73,380
| New | +$3.52M |
|
|
SPLS
1618
DELISTED
Staples Inc
SPLS
| $3.44M | 0.01% |
+211,078
| New | +$3.54M |
|
|
SALE
1619
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $3.43M | 0.01% |
190,631
+29,192
| +18% | +$477K |
|
|
BLUE
1620
DELISTED
bluebird bio
BLUE
| $3.43M | 0.01% |
2,194
+463
| +27% | +$611K |
|
1621
U-Haul Holding Co
UHAL
$14.3B
| $3.42M | 0.01% |
103,660
+11,630
| +13% | +$360K |
|
1622
Sarepta Therapeutics
SRPT
$1.68B
| $3.41M | 0.01% |
257,088
-84,206
| -25% | -$1.12M |
|
1623
PUT
Autodesk
ADSK
$47.7B
| $3.41M | 0.01% |
58,200
-20,000
| -26% | -$1.18M |
|
1624
Verizon
VZ
$198B
| $3.4M | 0.01% |
69,953
-273,766
| -80% | -$13.2M |
|
|
BSFT
1625
DELISTED
BroadSoft, Inc.
BSFT
| $3.4M | 0.01% |
101,644
+17,560
| +21% | +$527K |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.